Experimental antiviral drug with potential activity against RNA viruses
Favipiravir ▸ Facts ▸ Comments ▸ News ▸ Videos
Favipiravir, sold under the brand name Avigan among others, is an antiviral medication used to treat influenza in Japan. It is also being studied to treat a number of other viral infections. Like the experimental antiviral drugs T-1105 and T-1106, it is a pyrazinecarboxamide derivative.
You Might Like
COVID-19 medicine: Lupin launches Favipiravir in India at Rs 49 per tabletFavipiravir has received authorisation from the Drug Controller General of India (DCGI) for emergency use on COVID-19 patients as a potential treatment
Cipla to launch COVID-19 treatment drug Favipiravir: CSIRThe death toll has gone up to 30,601 with 740 fatalities reported in the last 24 hours.
Anti-viral drug Favipiravir shows clinical improvement in mild, moderate COVID-19 cases: GlenmarkGlenmark announced the launch of the first oral Favipiravir claiming that it is backed by strong clinical evidence showing encouraging results in patients with mild to moderate COVID-19.
Fujifilm says COVID-19 drug research may drag on into JulyFujifilm Holdings Corp's research on Avigan as a potential treatment for COVID-19 may drag on until July, the company said on Sunday, a further setback in the Japanese firm's race to find a vaccine.
Russia backing antiviral drug Avifavir for Covid-19 fight good news for India, say scientistsRussia's approval of the antiviral drug Avifavir to treat Covid-19 is good news for India as it is based on an influenza medication already in advanced clinical trials here, say scientists.Avifavir,..
Mumbai firm may become first in India to develop anti-retroviral drug for Covid-19In an indication of innovation in pharmaceuticals for Covid, Mumbai-based Glenmark may become the first company in India to offer an anti-retroviral, Favipiravir, from a class of drugs which has shown..
Covid-19: Mumbai firm seeks regulator nod for ARV trialsIn an indication of innovation in pharmaceuticals for Covid-19, Mumbai-based Glenmark may become the first company in India to offer an anti-retroviral, a class of drugs which has shown promise, and is..